1,685
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China

, , , , , , & show all
Article: 2310960 | Received 21 Aug 2023, Accepted 04 Jan 2024, Published online: 07 Feb 2024

Figures & data

Table 1. Patient population.

Table 2. Treatment response of IA and DA group.

Table 3. Response rate of IA and DA groups according to cytogenetic.

Table 4. Response rate of IA and DA groups according to age.

Table 5. Response rate of IA and DA groups according to FAB classification.

Table 6. Response rate of IA and DA groups according to different induction remission courses.

Table 7. Comparison of side effects of IA and DA groups.

Figure 1. Survival based on treatment. Kaplan-Meier curves of (A) OS and (B) PFS for both systemic therapy.

Figure 1. Survival based on treatment. Kaplan-Meier curves of (A) OS and (B) PFS for both systemic therapy.

Figure 2. Survival based on treatment. Kaplan-Meier curves of (A) OS (B) PFS for both systemic therapy in patients with CR after the second course of treatment.

Figure 2. Survival based on treatment. Kaplan-Meier curves of (A) OS (B) PFS for both systemic therapy in patients with CR after the second course of treatment.

Table 8. The number of MRD positive cases and clinical recurrences in the DA and IA groups.

Table 9. The relationship between recurrence and MRD in the DA and IA groups.

Table 10. The relationship between recurrence time and MRD in the DA and IA groups.

Table 11. Comparison of general conditions of patients after allo-HSCT in the DA and IA groups.

Table 12. Univariate analysis of prognostic factors for overall survial and progression-free survival.

Table 13. Multivariate Cox regression analysis of prognostic factors for OS.

Table 14. Comparison of OS and PFS after transplantation.

Data availability

The original datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.